CLASS II ONGOING Device recall · Reported 1 Oct 2025 · FDA Enforcement Report

FilmArray Ngds Warrior Panel Ngds-asy-0007 is a qualitative recalled

Biofire Defense is recalling FilmArray Ngds Warrior Panel Ngds-asy-0007 is a qualitative, multiplexed, nucleic, distributed nationwide in the US. The recall was initiated on 10 Jul 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00851458005136. Lot(Expiration): 324324D(2026-02-19), D241022(2026-01-22), 319524D(2025-11-20), 315424D(2025-10-09), 315224D(2025-10-03), 315324D(2025-10-08)
Quantity recalled130 Kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2609-2025
FDA event ID
97286
Recalling firm
Biofire Defense, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
10 Jul 2025
FDA classified
19 Sep 2025
Reported
1 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

10 Jul 2025Recall initiated by company
19 Sep 2025Classified by FDA+71 days
1 Oct 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.

Where it was distributed

US Nationwide distribution in the states of AL, AZ, UT, CA, TX, DC , VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA.

Nationwide AlabamaArizonaCaliforniaDistrict of ColumbiaFloridaHawaiiIowaKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriNorth CarolinaNew HampshireNevadaNew YorkOhioRhode Island

Questions about this recall

Is FilmArray Ngds Warrior Panel Ngds-asy-0007 is a qualitative, multiplexed, nucleic recalled?

Yes. Biofire Defense recalled FilmArray Ngds Warrior Panel Ngds-asy-0007 is a qualitative, multiplexed, nucleic on 10 Jul 2025. The recall is Class II and its status is Ongoing. Recall number Z-2609-2025.

Why was it recalled?

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

Which lots are affected?

UDI-DI: 00851458005136. Lot(Expiration): 324324D(2026-02-19), D241022(2026-01-22), 319524D(2025-11-20), 315424D(2025-10-09), 315224D(2025-10-03), 315324D(2025-10-08)

Where was it sold?

US Nationwide distribution in the states of AL, AZ, UT, CA, TX, DC , VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biofire Defense

All 4

Other Test Kits & Diagnostics recalls

All 2,656